• 1
    Layfield LJ, Glasgow BJ, Cramer H. Fine-needle aspiration in the management of breast masses. Pathol Annu 1989; 24 (Part II): 23–62.
  • 2
    Bibbo M, Scheiber M, Cajulis R, Keebler CM, Wied DL, Dowlatshahi K. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions. Acta Cytol 1988; 32: 193201.
  • 3
    Robinson IA, McKee G, Jackson PA, Cook MG, Kissin MW. Lobular carcinoma of the breast: cytological features supporting the diagnosis of lobular cancer. Diagn Cytopathol 1995; 13: 196201.
  • 4
    Robinson IA, McKee G, Nicholson A, D'Arcy J, Jackson PA, Cook MG, et al. Prognostic value of cytological grading of fine-needle aspirates from breast carcinomas. Lancet 1994; 343: 9479.
  • 5
    Azavedo E, Svane G, Auer G. Stereotactic fine-needle biopsy in 2594 mammographically detected non-palpable lesions. Lancet 1989; I: 1033–5.
  • 6
    Harris J, Lippman M, Veronesi U, Willett W. Breast cancer. N Engl J Med 1992; 327: 31928.
  • 7
    Fisher E, Constantine J, Fisher B, Redmond C. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4); discriminants for 15-year survival. Cancer 1993; 71: 214150.
  • 8
    Schnitt SJ, Silen W, Sadowsky NL, Connolly IL, Harris JR. Ductal carcinoma in situ (intraductal carcinoma) of the breast. N Engl J Med 1988; 318: 898903.
  • 9
    Beahrs OS, Shapiro S, Smart C. Report of the working group to review the National Cancer Institute–American Cancer Society breast cancer demonstration projects. J Natl Cancer Inst 1979; 62: 643709.
  • 10
    Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ 1988; 287(6654): 9438.
  • 11
    Elston CW, Ellis IO. Pathology and breast screening [invited review]. Histopathology 1990; 16: 10918.
  • 12
    Lagios MD. Duct carcinoma in situ: pathology and treatment. Surg Clin North Am 1990; 70: 85371.
  • 13
    Holland R, Peterse JL, Mills RR. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 1994; 11: 16780.
  • 14
    Sloane JP and members of the Royal College of Pathologists' Working Group. The National Coordinating Group for Breast Cancer Screening. 2nd edition. NHSBSP publication No. 3, April 1995.
  • 15
    Holland R, Hendriks JHCLI, Verbeek ALM, Mravunac M, Schuurman S, Sekhoven JH. Extent, distribution and mammographic histological correlations of breast ductal carcinoma in situ. Lancet 1990: 335: 51922.
  • 16
    Moriya T, Silverberg SG. Intraductal carcinoma (ductal carcinoma in situ) of the breast: a comparison of pure non-invasive tumors with those including different proportions of infiltrating carcinoma. Cancer 1994; 74: 29728.
  • 17
    Lodato RF, Maguire HC, Green MI, Weiner DB, Livolsi VA. Immunohistochemical evaluation of c-erb B-2 oncogene expression in ductal carcinoma in situ and atypical hyperplasia of the breast. Mod Pathol 1990; 3: 44954.
  • 18
    Matsukama A, Enjoji M, Toyoshima S. Ductal carcinoma of the breast: an analysis of proportions of intraductal and invasive components. Pathol Res Pract 1991: 187: 627.
  • 19
    Wang HH, Ducatman BS, Eick D. Comparative features of ductal carcinoma in sSitu and infiltrating ductal carcinoma of the breast on fine-needle aspiration biopsy. Diagn Cytopathol 1992; 8: 5716.
  • 20
    Sneige N, White V, Katz R, Troncoso P, Libshitz H, Hortobagyi GN. Ductal carcinoma in situ of the breast: fine-needle aspiration cytology of 12 cases. Diagn Cytopathol 1989; 5: 3717.
  • 21
    Theocharous C, Greenburg M. Cytologic features of ductal carcinoma in situ. Diagn Cytopathol 1996; 15: 36773.
  • 22
    Bobrow LG, Millis RR. The pathology of ductal carcinoma in situ of the breast. Clin Oncol 1995; 7: 2325.
  • 23
    Shin HJC, Sneige N. Is a diagnosis of infiltrating versus in situ ductal carcinoma of the breast possible in fine-needle aspiration specimens? Cancer (Cancer Cytopathol) 1998; 84: 18691.
  • 24
    Bondeson L, Lindholm K. Prediction of invasiveness by aspiration cytology applied to nonpalpable breast carcinoma and tested in 300 cases. Diagn Cytopathol 1997; 17: 31520.
  • 25
    Maygarden SJ, Brock MS, Novotny DB. Are epithelial cells in fat of connective tissue a reliable indicator of tumor invasion in fine-needle aspiration of the breast? Diagn Cytopathol 1997; 16: 13742.
  • 26
    Venegas R, Rutgers JL, Cameron BL, Vargas H, Butler JA. Fine needle aspiration cytology of breast ductal carcinoma in situ. Acta Cytol 1994; 38: 1369.
  • 27
    Malamud YR, Ducatman BS, Wang HH. Comparative features of comedo and noncomedo ductal carcinoma in situ of the breast on fine-needle aspiration biopsy. Diagn Cytopathol 1992; 8: 5716.
  • 28
    Lilleng R, Hagmar BM, Farrants G. Low-grade cribriform ductal carcinoma in situ of the breast: fine needle aspiration cytology in three cases. Acta Cytol 1992; 36: 4854.